The same phenomenon seems to occur in PD (Keeney et al., 2009; Pacelli et al., 2011) and PGC-1α is under investigation in new PD studies such as Pioglitazone in Early PD2 (FS-ZONE). This evidence concerns the gene PPARGC1A and Parkinson disease.